Glucose Health, Inc. (GLUC) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
Market cap $5.14M is the value of all shares combined. Beta 1.13: the stock has moved about 13% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerGlucose Health, Inc. (GLUC) trades at $0.30. Glucose Health, Inc. is a consumer defensive company specializing in soluble fiber-enriched nutritional beverages aimed at individuals managing pre-diabetes and diabetes. Market cap: $5.14M, Sector: Consumer defensive.
Price as of Sep 11, 2026 · Last analyzed: Jun 14, 2026Analyst Coverage for GLUC: GLUC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GLUC against Consumer Defensive peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
These figures come from statements filed 12 months ago — the most recent this company has published.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
GLUC: 1/2 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Glucose Health, Inc. (GLUC) Consumer Business Overview
Glucose Health, Inc. focuses on producing soluble fiber-enriched nutritional beverages under the GLUCODOWN brand, catering specifically to individuals with pre-diabetes and diabetes in the North American market, positioning itself within the growing dietary supplement sector.
What Is the Investment Thesis for GLUC?
Glucose Health, Inc. presents a unique investment thesis driven by its focus on the growing dietary supplement market, particularly for products aimed at individuals with pre-diabetes and diabetes. The market for diabetes-related health products is projected to expand significantly, reflecting an increasing consumer demand for health-oriented solutions. With a current market capitalization of $5.14M and a gross margin of 35%, the company is positioned to leverage its niche offerings to capture market share. However, the company faces challenges, including a negative profit margin of -66.6%, which highlights the need for operational improvements and effective marketing strategies. As the awareness of diabetes management continues to rise, Glucose Health's ability to innovate and adapt to market trends will be crucial for its growth trajectory. The company's ongoing efforts to promote its GLUCODOWN brand could serve as a catalyst for future revenue growth, especially as health-conscious consumers increasingly seek out functional beverages.
Based on FMP financials and quantitative analysis
GLUC Key Highlights
Market capitalization of $5.14M indicates a small but focused market presence.
- Gross margin of 35.0% reflects a relatively healthy profitability structure for a niche player.
- Negative profit margin of -66.6% indicates challenges in operational efficiency.
- Beta of 1.13 suggests that GLUC's stock price is slightly more volatile than the market average.
- No dividend yield, indicating a focus on reinvestment rather than shareholder returns.
Who Are GLUC's Competitors?
GLUC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| MDLZ Mondelez International, Inc. | $62.47 | +0.08% | $79.7B | 645-pillar |
| K Kellanova | $83.44 | -0.01% | $29.0B | — |
| DDC DDC Enterprise Limited | $0.25 | +1.78% | $6.09M | — |
| HCWC Healthy Choice Wellness Corp. | $9.65 | +13.53% | $6.27M | — |
| PLAG Planet Green Holdings Corp. | $0.72 | +1.57% | $10.2M | — |
| NAII Natural Alternatives International, Inc. | $2.02 | +1.00% | $12.7M | 365-pillar |
| COOT Australian Oilseeds Holdings Limited Ordinary Shares | $0.48 | +2.65% | $14.3M | — |
| MWYN Marwynn Holdings, Inc. | $0.93 | +5.83% | $18.8M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GLUC's Key Strengths?
Specializes in a growing niche market focused on diabetes management.
- Established brand presence with GLUCODOWN products.
- Strong commitment to quality and health-oriented solutions.
What Are GLUC's Weaknesses?
Limited workforce of only three employees may hinder growth.
- Negative profit margin indicates operational challenges.
- Small market capitalization may limit access to capital for expansion.
What Could Drive GLUC Stock Higher?
Expansion of product lines to include new flavors and functional beverages.
- Increasing consumer awareness and demand for diabetes-related health products.
- Strategic marketing efforts to enhance brand visibility and market reach.
What Are the Key Risks for GLUC?
Financial-distress signal — its Altman Z-Score of -40.60 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Regulatory changes affecting the dietary supplement industry.
- Competition from established brands in the packaged foods market.
- Operational challenges due to a small workforce and negative profit margins.
What Are the Growth Opportunities for GLUC?
- Growing Demand for Health-Oriented Beverages: The global market for health-oriented beverages is projected to reach $1 trillion by 2027, driven by increasing health consciousness among consumers. Glucose Health's focus on soluble fiber-enriched drinks positions it well to capture a share of this expanding market, particularly among individuals managing diabetes.
- Expansion of Product Lines: Glucose Health has the opportunity to diversify its product offerings beyond iced tea and flavored drink mixes. By introducing new flavors or functional beverages that cater to specific dietary needs, the company can attract a broader customer base and increase market penetration over the next 2-3 years.
- Strategic Partnerships and Collaborations: Forming partnerships with health organizations or diabetes advocacy groups can enhance Glucose Health's brand visibility and credibility. Collaborations could lead to co-marketing opportunities and access to new distribution channels, potentially increasing sales and market reach within the next 12-24 months.
- E-commerce Growth: The shift towards online shopping presents a significant opportunity for Glucose Health to expand its reach. By enhancing its online presence and utilizing digital marketing strategies, the company can tap into the growing e-commerce market for health products, which is projected to grow by 20% annually over the next five years.
- Increased Focus on Preventive Health: As healthcare shifts towards preventive measures, Glucose Health's products align with consumer trends favoring dietary solutions for health management. This alignment can drive demand for its offerings, particularly as awareness of diabetes and pre-diabetes continues to rise.
What Threats Does GLUC Face?
- Intense competition from established brands in the packaged foods sector.
- Regulatory scrutiny associated with dietary supplements.
- Market volatility impacting consumer spending on health products.
What Are GLUC's Competitive Advantages?
- Niche focus on soluble fiber-enriched beverages for diabetes management.
- Strong brand identity through the GLUCODOWN product line.
- Commitment to quality and innovation in product development.
- Growing awareness and demand for health-oriented dietary solutions.
- Ability to adapt to changing consumer preferences in the health sector.
What Does GLUC Do?
Founded in 2007 as Bio-Solutions Corp., Glucose Health, Inc. rebranded in November 2014, establishing its current identity. The company's headquarters is located in Bentonville, Arkansas, where it specializes in the creation, production, promotion, and distribution of nutritional beverages enriched with soluble fiber. Its flagship product line, GLUCODOWN, includes powdered iced tea and various flavored drink mixes, specifically formulated to support individuals managing pre-diabetes and diabetes. With a focus on health and wellness, Glucose Health aims to address the increasing prevalence of diabetes and related health issues in North America. The company operates in a niche market, targeting consumers who are health-conscious and seeking dietary solutions to manage their glucose levels effectively. Despite having a small workforce of just three employees, Glucose Health's strategic positioning in the dietary supplement space allows it to capitalize on the growing demand for diabetes-related health products. The company's commitment to innovation and quality in its product offerings has enabled it to carve out a unique space in the competitive landscape of packaged foods, where health-oriented products are increasingly sought after by consumers.
What Products and Services Does GLUC Offer?
- Develops soluble fiber-enriched nutritional beverages.
- Markets products specifically for individuals with pre-diabetes and diabetes.
- Offers powdered iced tea and flavored drink mixes under the GLUCODOWN brand.
- Focuses on health and wellness in the dietary supplement space.
- Operates primarily in the North American market.
- Promotes products aimed at managing blood sugar levels.
How Does GLUC Make Money?
- Generates revenue through the sale of nutritional beverages.
- Targets health-conscious consumers, particularly those managing diabetes.
- Utilizes branding and marketing strategies to promote the GLUCODOWN product line.
- Focuses on direct distribution and potential partnerships with retailers.
- Engages in promotional activities to increase brand awareness and product visibility.
What Industry Does GLUC Operate In?
The packaged foods industry is experiencing a notable shift towards health and wellness products, driven by increasing consumer awareness of dietary choices and their impact on health. The market for dietary supplements, particularly those targeting diabetes management, is expected to grow as the prevalence of diabetes rises globally. Glucose Health, Inc. operates within this expanding market, positioning itself to benefit from the trend towards healthier beverage options. Competitors in this space include established brands that have diversified into health-focused products, making it essential for Glucose Health to differentiate itself through quality and targeted marketing strategies.
Who Are GLUC's Key Customers?
- Individuals managing pre-diabetes and diabetes.
- Health-conscious consumers seeking dietary supplements.
- Retailers and distributors of health-oriented products.
- Fitness enthusiasts looking for functional beverages.
- Healthcare providers recommending dietary solutions for blood sugar management.
Research confidence
Enough evidence to be useful, with gaps worth knowing about.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 73 days ago
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 20 snapshots
| 2026-08-23 | 44 |
| 2026-08-27 | 44 |
| 2026-08-31 | 44 |
| 2026-09-04 | 44 |
| 2026-09-08 | 44 |
| 2026-09-11 | 44 |
What changed?
The score has stayed at 44.
Over the same 19 days the stock moved +18.4%.
Financial Health
Glucose Health, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -40.60 places it in the distress zone, a signal of elevated financial risk.
Quarterly Financial Performance: Glucose Health, Inc.
Revenue for Glucose Health, Inc. came in at $39K during Q2 FY2026, a 35.1% contraction versus the preceding quarter. The company recorded a net loss of $310K, with diluted EPS of $-0.01. Revenue has contracted over three consecutive quarters, which investors in this micro-cap Consumer Defensive stock should monitor closely. Across the four most recent quarters, GLUC averaged $-0.01 in diluted EPS.
GLUC Valuation & Market Position
With a $5.14M market cap, Glucose Health, Inc. sits in the micro-cap segment of the market.
Key Financial Metrics
Its free cash flow yield is -3.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.33 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -6.0%, the inverse of the P/E and a quick read on earnings relative to price.
Company Profile
Glucose Health, Inc. operates in the Packaged Foods industry within the Consumer Defensive sector. It is headquartered in Bentonville, US. The company is led by CEO John Duffy. GLUC has traded publicly since 2008.
GLUC Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Specializes in a growing niche market focused on diabetes management.
- Established brand presence with GLUCODOWN products.
- Strong commitment to quality and health-oriented solutions.
- Upcoming: Expansion of product lines to include new flavors and functional beverages.
Bear Case
- Limited workforce of only three employees may hinder growth.
- Negative profit margin indicates operational challenges.
- Small market capitalization may limit access to capital for expansion.
- Potential: Regulatory changes affecting the dietary supplement industry.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2026 | $38,830 | -$309,769 | -$0.01 |
| Q1 FY2026 | $59,823 | -$159,822 | -$0.01 |
| Q4 FY2025 | $125,343 | $9,226 | $0.0003 |
| Q3 FY2025 | $58,098 | -$75,757 | -$0.0044 |
Q2 FY2026 · filed 30 Jun 2026 · SEC EDGAR →
Based on FMP financials and quantitative analysis
GLUC Latest News
-
Stocks That Hit 52-Week Lows On Tuesday
· Mar 24, 2020
GLUC Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for GLUC.
Price Targets
Wall Street price target analysis for GLUC.
GLUC MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for GLUC; grades run from A+ (80-100) to F (below 30).
Leadership: Mark D. Schaftlein
CEO
Mark D. Schaftlein has been at the helm of Glucose Health, Inc. since its rebranding in 2014. With a background in business management and a strong focus on health-oriented products, he has guided the company through its evolution from Bio-Solutions Corp. to its current identity. His leadership emphasizes innovation in product development and strategic marketing.
Track Record: Under Mark's leadership, Glucose Health has successfully launched the GLUCODOWN brand and positioned itself within the dietary supplement market. His strategic decisions have focused on enhancing brand visibility and expanding product offerings tailored to health-conscious consumers.
GLUC OTC Market Information
The OTC Other tier represents companies that trade on the over-the-counter market but do not meet the requirements for higher tiers such as OTCQX or OTCQB. These companies often have less stringent reporting requirements, which can lead to less transparency and potentially higher risks for investors compared to those listed on major exchanges like NYSE or NASDAQ.
- OTC Tier: OTC Other
- Limited liquidity due to lower trading volumes compared to major exchanges.
- Potential lack of regulatory oversight may expose investors to higher risks.
- Increased volatility due to the small market capitalization and trading on the OTC market.
- Verify the company's financial health and operational performance.
- Assess the competitive landscape and market positioning.
- Review the management team's experience and track record.
- Investigate the regulatory environment for dietary supplements.
- Monitor industry trends and consumer demand for health products.
- Established brand presence with the GLUCODOWN product line.
- Track record of product development and market introduction.
- Commitment to quality and health-oriented solutions.
What Investors Ask About Glucose Health, Inc. (GLUC) — Consumer Defensive
Is GLUC a good stock?
Stock Expert AI does not rate GLUC buy, sell or hold. Glucose Health, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What are the main risks for GLUC?
Glucose Health, Inc. faces several risks, including limited liquidity due to its OTC trading status, which can result in wider bid-ask spreads and trading difficulties.
What are the key factors to evaluate for GLUC?
Evaluate GLUC on fundamentals, analyst consensus, and risk factors. Glucose Health, Inc. presents a unique investment thesis driven by its focus on the growing dietary supplement market, particularly for products aimed at individuals with pre-diabetes and diabetes. Not financial advice.
How frequently does GLUC data refresh on this page?
GLUC's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 calculations are scheduled daily at 10:15 UTC; the score's own date shows its last successful run.
What has driven GLUC's recent stock price performance?
Glucose Health, Inc. (GLUC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specializes in a growing niche market focused on diabetes management. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider GLUC overvalued or undervalued right now?
Glucose Health, Inc. (GLUC) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of GLUC?
Yes, most major brokerages offer fractional shares of Glucose Health, Inc. (GLUC) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track GLUC's earnings and financial reports?
Glucose Health, Inc. (GLUC) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for GLUC earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited financial disclosures available due to OTC trading status.